Yahoo
    Argus

    Argus

    •

    Aug 23, 2023

    QURE: What does Argus have to say about QURE?

    Symbols

    QURE

    Sector(s)

    Healthcare

    Rating

    Earnings Estimate

    Current Price

    $44.50

    Price Target

    Summary

    uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases.

    Upgrade to begin using premium research reports and get so much more.

    Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level

    Upgrade
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: